Abstract
The LaryngoscopeVolume 127, Issue 2 p. 289-290 Trio Society Best Practice Is bevacizumab effective for reducing epistaxis in hereditary hemorrhagic telangiectasia? Christopher J. Chin MD, FRCSC, Corresponding Author Christopher J. Chin MD, FRCSC christopher.chin@HorizonNB.ca Division of Otolaryngology–Head and Neck Surgery, Department of Surgery, Dalhousie Medicine New Brunswick, Saint John, New Brunswick, CanadaSend correspondence to Christopher J. Chin, MD, Division of Otolaryngology–Head and Neck Surgery, Department of Surgery, Dalhousie Medicine New Brunswick, 711 Millidge Avenue, Suite A, Saint John, NB, Canada E2K 2N7. E-mail: christopher.chin@HorizonNB.caSearch for more papers by this author Christopher J. Chin MD, FRCSC, Corresponding Author Christopher J. Chin MD, FRCSC christopher.chin@HorizonNB.ca Division of Otolaryngology–Head and Neck Surgery, Department of Surgery, Dalhousie Medicine New Brunswick, Saint John, New Brunswick, CanadaSend correspondence to Christopher J. Chin, MD, Division of Otolaryngology–Head and Neck Surgery, Department of Surgery, Dalhousie Medicine New Brunswick, 711 Millidge Avenue, Suite A, Saint John, NB, Canada E2K 2N7. E-mail: christopher.chin@HorizonNB.caSearch for more papers by this author First published: 31 October 2016 https://doi.org/10.1002/lary.26363Citations: 2 The author has no funding, financial relationships, or conflicts of interest to disclose. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume127, Issue2February 2017Pages 289-290 RelatedInformation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
